Alzheimer disease (AD) is characterized by deposition of amyloid β (Aβ) in senile plaques and hyperphosphorylated tau in neurofibrillary tangles,
1 which consist mainly of paired helical filaments (PHFs) comprising a mixture of 3- to 4-repeat tau isoforms.
2,3 Tau pathology is also seen in various non-AD neurodegenerative disorders, including progressive supranuclear palsy and other variants of frontotemporal lobar degeneration.
4 Tau deposits in these disorders, however, differ from the AD-type PHFs consisting of 3- to 4 repeat tau isoforms.
5 In AD, cortical neurofibrillary neurotangles are closely associated with neurodegeneration and onset of cognitive impairment.
6